2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016 Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and monitoring of multiple sclerosis made an important step towards appropriate use of MRI in routine clinical practice. Since their promulgation, there have been substantial relevant advances in knowledge, including the 2017 revisions of the McDonald diagnostic criteria, renewed safety concerns regarding intravenous gadolinium-based contrast agents, and the value of spinal cord MRI for diagnostic, prognostic, and monitoring purposes. These developments suggest a changing role of MRI for the management of patients with multiple sclerosis. This 2021 revision of the previous guidelines on MRI use for patients with multiple sclerosis merges recommendations from the Magnetic Resonance Imaging in Multiple Sclerosis study group, Consortium of Multiple Sclerosis Centres, and North American Imaging in Multiple Sclerosis Cooperative, and translates research findings into clinical practice to improve the use of MRI for diagnosis, prognosis, and monitoring of individuals with multiple sclerosis. We recommend changes in MRI acquisition protocols, such as emphasising the value of three dimensional-fluid-attenuated inversion recovery as the core brain pulse sequence to improve diagnostic accuracy and ability to identify new lesions to monitor treatment effectiveness, and we provide recommendations for the judicious use of gadolinium-based contrast agents for specific clinical purposes. Additionally, we extend the recommendations to the use of MRI in patients with multiple sclerosis in childhood, during pregnancy, and in the post-partum period. Finally, we discuss promising MRI approaches that might deserve introduction into clinical practice in the near future

Journal of Electron Spectroscopy and Related Phenomena 101--103 (1999) 257--262

The magnetic linear dichroism (MLD) was used to study the magnetic properties of Ni-ultrathin film grown on ferromagnetic substrate Co(001). The MLD in photoemission has been measured for either the valence Ni3d states around the Ni3p threshold or 3p core level. Our dichroism measurements of the valence Ni3d states conclude that the resonance effect is present on MLD for `6 eV-satellite' in the valence band photoemission whereas the main valence band peak shows nearly same MLD signal for the both on and off resonance. It is shown for the thinner film that the dichroism from Ni and Co3p core levels shows same sign with each other. This means that the Ni and Co are ferromagnetically coupled. 1999 Elsevier Science B.V. All rights reserved

Is epidemiology implicating extremely low frequency electric and magnetic fields in childhood leukemia?

We have reviewed epidemiological studies examining the association between residential exposure to extremely low frequency electric and magnetic fields (ELF-EMF) and childhood leukemia. We have excluded studies focusing on electrical appliances, because it is difficult to consolidate transient exposure from multiple sources and equally difficult to control information bias. We have identified 24 studies of residential exposure to ELF-EMF and childhood leukemia. About half of these studies were reported as positive and the remaining as null. For each of the studies reported as positive, however, one or more sources of bias could not be confidently excluded. Moreover, studies which were methodologically more sound, or benefited from high quality registry data, were more frequently null than other investigations. We conclude that the empirical evidence in support of an association between ELF-EMF and childhood leukemia is weak